Recombinant Thymidylate synthase (thyA)

Shipped with Ice Packs
In Stock

Description

Biochemical Mechanism and Functional Role

ThyA facilitates the sole de novo pathway for thymidylate synthesis via the reaction:
dUMP+CH2THFdTMP+DHF\text{dUMP} + \text{CH}_2\text{THF} \rightleftharpoons \text{dTMP} + \text{DHF}
This reaction is coupled with dihydrofolate reductase (FolA), which regenerates tetrahydrofolate (THF) from dihydrofolate (DHF) . Key features include:

  • Cofactor dependency: ThyA requires THF and is inhibited by trimethoprim, which blocks FolA .

  • Structural conservation: A cysteine residue in the active site forms a covalent bond with dUMP during catalysis .

Production of Recombinant ThyA

Recombinant ThyA is expressed in heterologous systems like Escherichia coli or insect cells (e.g., Sf9), often fused with affinity tags (e.g., polyhistidine) for purification .

ParameterSpecification
Expression HostSf9 cells
TagN-terminal polyhistidine
Purity>80% (SDS-PAGE)
Molecular Weight36 kDa
Buffer50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 10% glycerol
ApplicationsEnzyme assays, drug screening, structural studies

Data adapted from Origene’s recombinant ThyA product (TP710029) .

Selection Marker

  • Antibiotic-free selection: The thyA gene enables selection in thymidine-deficient media, avoiding antibiotic resistance genes. For example, Lactococcus lactis ThyA restored thymidine prototrophy in E. coli thyA mutants with 100% efficiency .

  • BAC modifications: ThyA-mediated recombineering achieved >90% efficiency in introducing point mutations into bacterial artificial chromosomes (BACs) without留下 unwanted sequences .

Gene Knockout Complementation

  • Haemophilus influenzae ΔthyA mutants exhibited thymidine auxotrophy, with growth restored by exogenous thymidine (300 μg/ml) .

Clinical and Biotechnological Relevance

  • Cancer therapy: ThyA is a target for 5-fluorouracil (5-FU), which forms a stable complex with the enzyme, disrupting DNA synthesis .

  • Antifolate resistance: Organisms relying on ThyX (a flavin-dependent thymidylate synthase) instead of ThyA show trimethoprim resistance, highlighting ThyA’s role in folate metabolism .

Experimental Data

  • Growth inhibition: Rhodobacter capsulatus ΔthyX mutants required both thyA and folA for thymidine prototrophy, underscoring functional coupling between ThyA and FolA .

  • Structural insights: Crystal structures of ThyA homologs (e.g., ThyX) revealed FAD-binding domains and catalytic motifs, aiding inhibitor design .

StrainGrowth ConditionOutcome
H. influenzae ΔthyAThymidine-deficient mediaNo growth; auxotrophy
H. influenzae ΔthyA+ thymidine (300 μg/ml)Partial growth restoration
E. coli HX2 + pPR204LB mediumThyA-complemented growth

Data synthesized from .

Challenges and Future Directions

  • Expression optimization: Low yields in eukaryotic systems (e.g., Sf9 cells) necessitate improved vector designs .

  • Therapeutic targeting: Structural studies of ThyA-inhibitor complexes could enhance drug specificity against pathogens and cancer cells .

Product Specs

Form
Lyophilized powder. We will ship the in-stock format preferentially. If you have special format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery times vary by purchase method and location. Consult your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs. For dry ice shipping, please contact us in advance; additional charges apply.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50% for your reference.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Liquid form is generally stable for 6 months at -20°C/-80°C. Lyophilized form is generally stable for 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
thyA; Thymidylate synthase; TS; TSase; EC 2.1.1.45
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-316
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Lactobacillus casei
Target Names
thyA
Target Protein Sequence
MLEQPYLDLA KKVLDEGHFK PDRTHTGTYS IFGHQMRFDL SKGFPLLTTK KVPFGLIKSE LLWFLHGDTN IRFLLQHRNH IWDEWAFEKW VKSDEYHGPD MTDFGHRSQK DPEFAAVYHE EMAKFDDRVL HDDAFAAKYG DLGLVYGSQW RAWHTSKGDT IDQLGDVIEQ IKTHPYSRRL IVSAWNPEDV PTMALPPCHT LYQFYVNDGK LSLQLYQRSA DIFLGVPFNI ASYALLTHLV AHECGLEVGE FIHTFGDAHL YVNHLDQIKE QLSRTPRPAP TLQLNPDKHD IFDFDMKDIK LLNYDPYPAI KAPVAV
Uniprot No.

Target Background

Function
Catalyzes the reductive methylation of 2'-deoxyuridine-5'-monophosphate (dUMP) to 2'-deoxythymidine-5'-monophosphate (dTMP) using 5,10-methylenetetrahydrofolate (mTHF) as the methyl donor and reductant, producing dihydrofolate (DHF). This reaction provides an intracellular de novo source of dTMP, an essential precursor for DNA biosynthesis.
Protein Families
Thymidylate synthase family, Bacterial-type ThyA subfamily
Subcellular Location
Cytoplasm.

Q&A

What is thymidylate synthase (thyA) and what is its role in nucleotide metabolism?

Thymidylate synthase (TS, EC 2.1.1.45) is a critical enzyme in the de novo biosynthesis pathway of 2'-deoxythymidine-5'-monophosphate (thymidylate, dTMP). It catalyzes the transfer of a methylene residue from N5,10-methylenetetrahydrofolate (meTHF) to deoxyuridine monophosphate (dUMP), resulting in the formation of 7,8-dihydrofolate (DHF) and dTMP . This reaction is essential for DNA synthesis and cell proliferation.

The biochemical pathway involves several interconnected enzymes:

  • Thymidylate synthase (TS) converts dUMP to dTMP

  • Dihydrofolate reductase (DHFR) reduces DHF to tetrahydrofolate (THF)

  • Serine hydroxymethyltransferase (SHMT) regenerates meTHF from THF

This enzymatic cascade maintains the supply of thymidylate necessary for DNA replication, making thyA an attractive target for both antimicrobial compounds and cancer therapeutics.

What are the common methods for expressing recombinant thymidylate synthase?

Methodological approaches for expressing recombinant thymidylate synthase include:

Expression Systems:

  • E. coli: Most commonly used host, particularly BL21(DE3) strains with T7 promoter-based vectors

  • Yeast: Suitable for proteins requiring eukaryotic post-translational modifications

  • Insect cells: Baculovirus expression systems for complex eukaryotic proteins

Expression Optimization:

  • Temperature reduction (16-25°C) during induction to enhance solubility

  • Co-expression with chaperones to improve folding

  • Addition of solubility-enhancing tags (MBP, SUMO, GST)

  • Use of codon-optimized synthetic genes to improve expression levels

Purification Strategy:

  • Affinity chromatography (His-tag, GST-tag)

  • Ion exchange chromatography for further purification

  • Size exclusion chromatography for final polishing and buffer exchange

  • Activity assays to confirm functional enzyme recovery

The specific approach should be tailored to research requirements, considering yield, purity, activity, and downstream applications.

How does recombinant thymidylate synthase differ from native enzyme?

Recombinant thymidylate synthase may differ from the native enzyme in several important ways:

Structural Differences:

  • Addition of affinity tags (His, GST) that may affect folding or activity

  • Potential changes in post-translational modifications, including phosphorylation

  • Altered oligomeric state depending on expression conditions

Functional Considerations:

  • Catalytic efficiency may vary compared to the native enzyme

  • Substrate affinity can be affected by recombinant production

  • Stability profiles often differ due to purification processes

Post-translational Modifications:

  • Research has confirmed that recombinant thymidylate synthase can be phosphorylated by CK2

  • Other modifications like acetylation or methylation may be absent in recombinant systems

  • These differences can impact enzyme regulation and activity

When designing experiments with recombinant thyA, researchers should validate that the recombinant enzyme reflects the properties of the native enzyme in their specific experimental context.

What experimental designs are most suitable for thymidylate synthase research?

Appropriate experimental design is crucial for thymidylate synthase research. The following approaches are recommended:

Completely Randomized Design (CRD):

  • Suitable for homogeneous experimental material

  • All experimental units have equal probability of receiving treatments

  • Particularly useful for in vitro enzyme assays

  • Allows flexibility in the number of treatments or replications

Design Considerations:

  • Define experimental units clearly (e.g., enzyme preparations, cell cultures)

  • Ensure sufficient replication (typically n≥3) for statistical power

  • Include appropriate controls (positive, negative, vehicle)

  • Randomize the order of treatments to minimize systematic errors

Data Analysis Approach:

  • Analysis of Variance (ANOVA) for comparing multiple treatments

  • Regression analysis for dose-response relationships

  • Non-linear regression for enzyme kinetics parameters

  • Appropriate post-hoc tests for multiple comparisons

Experimental Design ElementRecommendation for thyA Research
Minimum replications3-6 per treatment group
Control groupsInclude enzyme-free, substrate-free, and known inhibitor controls
RandomizationEssential to minimize batch effects
Blocking factorsConsider enzyme preparation, substrate lot, temperature variations

Careful experimental design increases reproducibility and validity of research findings.

How does phosphorylation affect thymidylate synthase activity and regulation?

Research by Prof. Rode's team has demonstrated that recombinant thymidylate synthase undergoes phosphorylation by protein kinase CK2 . This post-translational modification has significant implications for enzyme function and regulation:

Phosphorylation Mechanisms:

  • CK2 specifically phosphorylates serine/threonine residues in thymidylate synthase

  • The modification introduces negative charges that can alter protein conformation

  • Phosphorylation sites often occur at regulatory interfaces or near catalytic regions

Functional Consequences:

  • Changes in catalytic efficiency (kcat/Km)

  • Altered substrate binding affinities

  • Modified protein-protein interaction profiles

  • Potential impacts on subcellular localization

Regulatory Implications:

  • Phosphorylation may couple thymidylate synthesis to cell cycle progression

  • This modification potentially integrates nucleotide metabolism with cellular signaling pathways

  • Creates potential for feedback regulation by intracellular conditions

Methodologically, researchers can investigate phosphorylation effects through:

  • Site-directed mutagenesis of potential phosphorylation sites

  • In vitro phosphorylation assays with purified CK2

  • Activity measurements comparing phosphorylated versus non-phosphorylated forms

  • Structural studies to identify conformational changes

This research area represents a critical intersection between post-translational modifications and metabolic enzyme regulation.

How can thymidylate synthase be effectively used in DNA recombineering applications?

Thymidylate synthase (thyA) has emerged as a powerful tool in DNA recombineering, providing advantages over traditional selection markers:

Mechanism and Implementation:

  • λ-Red system-based recombineering uses thyA as a single selectable marker

  • thyA-deficient strains require exogenous thymidine for growth

  • Complementation with functional thyA allows growth on minimal media lacking thymidine

  • Creates an efficient positive/negative selection system without restriction enzymes or ligases

Methodological Protocol:

  • Generate a thyA-deficient bacterial strain

  • Introduce the λ-Red recombination system (typically via temperature-sensitive plasmid)

  • Design DNA fragments with homology arms (40-50bp) flanking the thyA gene

  • Transform bacteria and select recombinants on minimal media lacking thymidine

  • Verify recombination by PCR and sequencing

Advantages over Traditional Methods:

  • Eliminates the need for antibiotic resistance markers

  • Enables seamless DNA engineering without scar sequences

  • Allows for iterative genetic modifications

  • Compatible with large DNA constructs like BACs

Experimental Design Considerations:

  • Optimize electroporation conditions for efficient DNA uptake

  • Carefully control temperature for λ-Red expression

  • Include appropriate controls to verify recombination efficiency

  • Consider homology arm length and GC content for optimal recombination

This approach has revolutionized DNA engineering by providing a more efficient and seamless recombineering methodology .

What are the latest analytical techniques for studying thymidylate synthase-inhibitor interactions?

Advanced methodological approaches for analyzing interactions between thymidylate synthase and potential inhibitors include:

Biophysical Techniques:

  • Surface Plasmon Resonance (SPR): Provides real-time binding kinetics

  • Isothermal Titration Calorimetry (ITC): Offers thermodynamic binding parameters

  • Microscale Thermophoresis (MST): Allows analysis with minimal sample consumption

  • Bio-Layer Interferometry (BLI): Enables label-free interaction detection

Structural Analysis Methods:

  • X-ray Crystallography: Determines atomic resolution structures of enzyme-inhibitor complexes

  • Cryo-Electron Microscopy: Achieves near-atomic resolution without crystallization

  • Hydrogen-Deuterium Exchange Mass Spectrometry: Maps conformational changes upon binding

  • NMR Spectroscopy: Provides dynamics information and identifies binding sites

Computational Approaches:

  • Molecular Dynamics Simulations: Explore binding pathway dynamics

  • Quantum Mechanics/Molecular Mechanics: Models electronic structure changes during binding

  • Free Energy Calculations: Predicts binding affinities and energetic contributions

  • Machine Learning-Based Screening: Identifies novel inhibitor scaffolds

Enzyme Kinetics Methods:

  • Progress Curve Analysis: Detects time-dependent inhibition

  • Global Fitting Approaches: Differentiates competitive, uncompetitive, and mixed inhibition

  • Stopped-Flow Kinetics: Resolves fast binding events

Each technique provides complementary information, and combining multiple approaches yields the most comprehensive understanding of inhibitor binding and mechanism.

How can contradictory data in thymidylate synthase research be reconciled and analyzed?

When facing contradictory results in thymidylate synthase research, systematic methodological approaches can help reconcile discrepancies:

Sources of Contradictions:

  • Variations in experimental conditions (pH, temperature, buffer composition)

  • Differences in enzyme preparations (native vs. recombinant, tagged vs. untagged)

  • Post-translational modifications like phosphorylation by CK2

  • Species-specific variations in enzyme properties

  • Methodological differences in activity assays

Analytical Approach:

  • Standardize Experimental Conditions:

    • Create a standardized protocol across laboratories

    • Use identical buffer systems and assay conditions

    • Calibrate instruments with common standards

  • Characterize Enzyme Preparations:

    • Verify enzyme purity by SDS-PAGE and mass spectrometry

    • Confirm post-translational modification status

    • Determine oligomeric state by size exclusion chromatography

  • Apply Statistical Methods:

    • Use meta-analysis to integrate multiple datasets

    • Implement Analysis of Variance (ANOVA) to identify significant factors

    • Create experimental designs that account for multiple variables

  • Conduct Mechanistic Investigations:

    • Perform site-directed mutagenesis to test hypotheses

    • Use multiple complementary assay methods

    • Examine enzyme kinetics under varying conditions

Potential ContradictionResolution Approach
Activity differences between labsRound-robin testing with identical samples
Inhibitor potency variationsStandardized binding assays with reference compounds
Phosphorylation effectsControlled phosphorylation/dephosphorylation experiments
Species-specific differencesPhylogenetic analysis and structural comparisons

This systematic approach helps distinguish genuine biological differences from methodological artifacts.

What role does thymidylate synthase play in antibiotic resistance and how can this be studied?

Thymidylate synthase has significant implications for antibiotic resistance, particularly for antimicrobials targeting folate metabolism:

Resistance Mechanisms:

  • Mutations in thyA altering binding sites for antifolate drugs

  • Overexpression of thymidylate synthase decreasing susceptibility

  • Acquisition of plasmid-encoded resistant thyA variants

  • Metabolic bypasses that reduce dependency on de novo thymidylate synthesis

Methodological Approaches for Investigation:

  • Genomic Analysis:

    • Whole genome sequencing to identify resistance-associated mutations

    • Comparative genomics across resistant and susceptible strains

    • PCR-based screening for known resistance markers in thyA

  • Biochemical Characterization:

    • Enzyme kinetic analysis of wild-type and mutant enzymes

    • Inhibitor binding studies using SPR or ITC

    • IC50 determination for antifolates against purified enzyme variants

  • Structural Biology:

    • X-ray crystallography of resistant thyA variants

    • Structure-based computational modeling of binding alterations

    • Molecular dynamics simulations of resistance-conferring mutations

  • Microbiology Techniques:

    • Minimum inhibitory concentration (MIC) determinations

    • Time-kill kinetics with antifolate compounds

    • Selection of resistant mutants under antifolate pressure

    • Complementation studies with cloned thyA variants

  • Experimental Design Considerations:

    • Complete randomized design for comparing multiple thyA variants

    • Include appropriate control strains (susceptible and resistant)

    • Ensure sufficient biological replicates for statistical power

    • Account for growth rate differences between strains

Understanding thyA-mediated resistance mechanisms is crucial for developing strategies to overcome antimicrobial resistance and designing next-generation inhibitors.

How do species-specific variations in thymidylate synthase impact experimental design and interpretation?

Thymidylate synthase exhibits significant variation across species, necessitating careful consideration in experimental design and data interpretation:

Key Species Differences:

  • Structural variations in active site architecture

  • Divergent regulatory mechanisms and allosteric sites

  • Different post-translational modifications (e.g., phosphorylation patterns)

  • Variation in oligomeric state (predominantly homodimeric, but exceptions exist)

  • Species-specific inhibitor sensitivity profiles

Methodological Implications:

  • Choice of Experimental Model:

    • Select species appropriate for research question (human for drug development, bacterial for antibiotic studies)

    • Consider evolutionary distance when extrapolating findings

    • Account for differences in expression systems when using recombinant enzymes

  • Comparative Analysis Approach:

    • Implement side-by-side testing of enzymes from multiple species

    • Use standardized assay conditions with species-specific optimizations

    • Apply phylogenetic corrections when analyzing evolutionary patterns

  • Experimental Design Considerations:

    • Include species as a blocking factor in statistical designs

    • Ensure sufficient replication across species

    • Use factorial designs to test species-inhibitor interactions

    • Control for enzyme concentration and purity differences

  • Data Interpretation Framework:

    • Avoid direct numerical comparisons across species without normalization

    • Consider structural basis for functional differences

    • Account for physiological context and native regulatory mechanisms

    • Use appropriate controls specific to each species studied

SpeciesNotable thyA CharacteristicsExperimental Considerations
HumanLarger binding pocket, unique C-terminal regionRelevant for drug development, slower kinetics
E. coliWell-characterized, commonly used in recombineering Excellent model system, rapidly expressed
MycobacteriaContains insertions, altered substrate bindingDrug-resistant variants common, slower growth
PlasmodiumPart of bifunctional DHFR-TS enzymeSpecial expression systems required

Understanding these species-specific variations is essential for designing rigorous experiments and correctly interpreting results across different model systems.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.